Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer

Ann Oncol. 2011 Jan;22(1):235-237. doi: 10.1093/annonc/mdq680.

Authors

M C Garassino¹, M Marabese², P Rusconi², E Rulli³, O Martelli⁴, G Farina⁵, A Scanni⁶, M Broggini²

Affiliations

¹ Division of Medical Oncology, Fatebenefratelli and Oftalmico Hospital. Electronic address: [email protected].
² Laboratory of Molecular Pharmacology.
³ Laboratory of Clinical Trial, Department of Oncology, "Mario Negri" Institute, Milan.
⁴ Division of Medical Oncology, San Giovanni Hospital, Rome.
⁵ Division of Medical Oncology, Fatebenefratelli and Oftalmico Hospital.
⁶ General Direction, "Luigi Sacco" Hospital, Milan, Italy.

PMID: 21169473
DOI: 10.1093/annonc/mdq680

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / genetics*
Carcinoma, Non-Small-Cell Lung / pathology
Cell Line, Tumor
Genes, ras*
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / genetics*
Lung Neoplasms / pathology
Mutation*